Foghorn Therapeutics Files Q1 2025 10-Q
Ticker: FHTX · Form: 10-Q · Filed: May 14, 2025 · CIK: 1822462
| Field | Detail |
|---|---|
| Company | Foghorn Therapeutics Inc. (FHTX) |
| Form Type | 10-Q |
| Filed Date | May 14, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, pharmaceuticals, financials
Related Tickers: FHTX
TL;DR
Foghorn Tx (FHTX) Q1 2025 10-Q filed. Check financials.
AI Summary
Foghorn Therapeutics Inc. filed its 10-Q for the period ending March 31, 2025. The company, headquartered in Cambridge, MA, operates in the pharmaceutical preparations sector. Key financial data and operational details for the first quarter of 2025 are presented in this filing.
Why It Matters
This filing provides investors and analysts with the latest financial performance and operational updates for Foghorn Therapeutics, crucial for assessing the company's current standing and future prospects.
Risk Assessment
Risk Level: medium — As a pharmaceutical company, Foghorn Therapeutics is subject to inherent risks related to drug development, regulatory approvals, and market competition.
Key Numbers
- 2025 Q1 — Reporting Period (Indicates the first quarter of fiscal year 2025.)
- 2025-03-31 — As of Date (The specific date as of which the report is filed.)
- 2024-12-31 — Prior Year End (Provides a comparison point to the end of the previous fiscal year.)
Key Players & Entities
- Foghorn Therapeutics Inc. (company) — Filer of the 10-Q
- 20250331 (date) — End of the reporting period
- Cambridge, MA (location) — Company headquarters
- 2834 (industry_code) — Standard Industrial Classification for Pharmaceutical Preparations
- 001-39634 (sec_file_number) — SEC file number for Foghorn Therapeutics Inc.
FAQ
What is the primary business of Foghorn Therapeutics Inc.?
Foghorn Therapeutics Inc. operates in the Pharmaceutical Preparations sector, as indicated by its SIC code 2834.
What is the reporting period for this 10-Q filing?
The reporting period for this 10-Q filing is the first quarter of 2025, ending on March 31, 2025.
Where is Foghorn Therapeutics Inc. headquartered?
Foghorn Therapeutics Inc. is headquartered in Cambridge, MA.
What is the SEC file number for Foghorn Therapeutics Inc.?
The SEC file number for Foghorn Therapeutics Inc. is 001-39634.
When was this 10-Q filing submitted?
This 10-Q filing was submitted on May 14, 2025.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 14, 2025 regarding Foghorn Therapeutics Inc. (FHTX).